CT-0525
Study 102
Phase 1 small_molecule active
Quick answer
CT-0525 for HER2-positive is a Phase 1 program (small_molecule) at Carisma Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Carisma Therapeutics
- Indication
- HER2-positive
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active